1. Home
  2. NBIX vs NICE Comparison

NBIX vs NICE Comparison

Compare NBIX & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • NICE
  • Stock Information
  • Founded
  • NBIX 1992
  • NICE 1986
  • Country
  • NBIX United States
  • NICE Israel
  • Employees
  • NBIX N/A
  • NICE N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • NICE Computer Software: Prepackaged Software
  • Sector
  • NBIX Health Care
  • NICE Technology
  • Exchange
  • NBIX Nasdaq
  • NICE Nasdaq
  • Market Cap
  • NBIX 13.1B
  • NICE 11.1B
  • IPO Year
  • NBIX 1996
  • NICE 1996
  • Fundamental
  • Price
  • NBIX $135.45
  • NICE $191.64
  • Analyst Decision
  • NBIX Buy
  • NICE Strong Buy
  • Analyst Count
  • NBIX 23
  • NICE 14
  • Target Price
  • NBIX $165.00
  • NICE $260.57
  • AVG Volume (30 Days)
  • NBIX 910.2K
  • NICE 381.4K
  • Earning Date
  • NBIX 02-05-2025
  • NICE 11-14-2024
  • Dividend Yield
  • NBIX N/A
  • NICE N/A
  • EPS Growth
  • NBIX 97.40
  • NICE 31.21
  • EPS
  • NBIX 3.73
  • NICE 6.47
  • Revenue
  • NBIX $2,242,800,000.00
  • NICE $2,636,864,000.00
  • Revenue This Year
  • NBIX $27.07
  • NICE $17.10
  • Revenue Next Year
  • NBIX $16.60
  • NICE $11.06
  • P/E Ratio
  • NBIX $36.12
  • NICE $27.95
  • Revenue Growth
  • NBIX 25.72
  • NICE 13.52
  • 52 Week Low
  • NBIX $110.95
  • NICE $151.52
  • 52 Week High
  • NBIX $157.98
  • NICE $270.73
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 68.12
  • NICE 55.50
  • Support Level
  • NBIX $125.61
  • NICE $184.34
  • Resistance Level
  • NBIX $130.48
  • NICE $191.35
  • Average True Range (ATR)
  • NBIX 2.92
  • NICE 5.55
  • MACD
  • NBIX 0.72
  • NICE 0.11
  • Stochastic Oscillator
  • NBIX 69.33
  • NICE 66.49

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice's CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.

Share on Social Networks: